Paper35580932
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.
Pinjusic K and 6 others. J Immunother Cancer, 2022. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. Papers, record 35580932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35580932
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Activins | Major topic |
| Melanoma | Major topic |
| Animals | |
| CD8-Positive T-Lymphocytes | |
| Humans | |
| Immunity, Cellular | |
| Inhibin-beta Subunits | |
| Mice | |
| Proto-Oncogene Proteins B-raf |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30540228 | Activin A in Mammalian Physiology. | Physiol Rev | 2019 | https://conductscience.org/library/papers/30540228 | PubMed |
| 2 | 32916126 | Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32916126 | PubMed |
| 3 | 17982055 | CD8 T cell help for innate antitumor immunity. | J Immunol | 2007 | https://conductscience.org/library/papers/17982055 | PubMed |
| 4 | 29483207 | Impact of Chemical-Induced Mutational Load Increase on Immune Checkpoint Therapy in Poorly Responsive Murine Tumors. | Mol Cancer Ther | 2018 | https://conductscience.org/library/papers/29483207 | PubMed |
| 5 | 33182504 | CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33182504 | PubMed |
| 6 | 24798330 | Nodal·Gdf1 heterodimers with bound prodomains enable serum-independent nodal signaling and endoderm differentiation. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24798330 | PubMed |
| 7 | 12364468 | Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells. | J Clin Endocrinol Metab | 2002 | https://conductscience.org/library/papers/12364468 | PubMed |
| 8 | 27287723 | The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations. | Pigment Cell Melanoma Res | 2016 | https://conductscience.org/library/papers/27287723 | PubMed |
| 9 | 19288218 | Regulatory expression of genes related to metastasis by TGF-beta and activin A in B16 murine melanoma cells. | Mol Biol Rep | 2010 | https://conductscience.org/library/papers/19288218 | PubMed |
| 10 | 31636098 | Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/31636098 | PubMed |
| 11 | 29643229 | T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. | Sci Transl Med | 2018 | https://conductscience.org/library/papers/29643229 | PubMed |
| 12 | 28844941 | Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion. | J Invest Dermatol | 2017 | https://conductscience.org/library/papers/28844941 | PubMed |
| 13 | 27364554 | BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo. | Cancer Res | 2016 | https://conductscience.org/library/papers/27364554 | PubMed |
| 14 | 28486109 | Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. | Cancer Cell | 2017 | https://conductscience.org/library/papers/28486109 | PubMed |
| 15 | 29312797 | Loss of ACVRIB leads to increased squamous cell carcinoma aggressiveness through alterations in cell-cell and cell-matrix adhesion proteins. | Am J Cancer Res | 2017 | https://conductscience.org/library/papers/29312797 | PubMed |
| 16 | 15196700 | Activin isoforms signal through type I receptor serine/threonine kinase ALK7. | Mol Cell Endocrinol | 2004 | https://conductscience.org/library/papers/15196700 | PubMed |
| 17 | 31570880 | Tumour-intrinsic resistance to immune checkpoint blockade. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31570880 | PubMed |
| 18 | 19293190 | Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. | Cancer Res | 2009 | https://conductscience.org/library/papers/19293190 | PubMed |
| 19 | 1899424 | Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production. | J Clin Endocrinol Metab | 1991 | https://conductscience.org/library/papers/1899424 | PubMed |
| 20 | 15520172 | CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease. | Cancer Res | 2004 | https://conductscience.org/library/papers/15520172 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42951965 | Tumour assembloids recapitulate tumour-CAF-T cell crosstalk in renal cancer. | Nature | 2026 | https://conductscience.org/library/papers/42951965 | PubMed |
| 42595443 | Deficiency in circulating T cells in four core genotypes mice with Sry translocation. | J Immunol | 2026 | https://conductscience.org/library/papers/42595443 | PubMed |
| 41985061 | A bio-inspired computational pipeline for antibody screening and repurposing. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/41985061 | PubMed |
| 41463203 | Sex Differences in the Response to Lung Cancer and Its Relation to Programmed Cell Death Protein-1/Programmed Death-Ligand-1 Checkpoint Therapies. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41463203 | PubMed |
| 41116748 | Single-Cell RNA Sequencing Identifies Accumulation of Fcgr2b + Virtual Memory-Like CD8 T Cells With Cytotoxic and Inflammatory Potential in Aged Mouse White Adipose Tissue. | Aging Cell | 2025 | https://conductscience.org/library/papers/41116748 | PubMed |
| 41102920 | Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity. | Mol Oncol | 2026 | https://conductscience.org/library/papers/41102920 | PubMed |
| 41091425 | Pan-cancer analysis of INHBA indicates its potential prognostic value and correlation with HNSC and LIHC. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41091425 | PubMed |
| 41054626 | Sirp-α Antibody Inhibits Renal Cell Carcinoma Progression via Akt1/Akt2 Modulation in Tumor-Associated Macrophages. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41054626 | PubMed |
| 40872475 | Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872475 | PubMed |
| 40303343 | Sex bias in tumor immunity: insights from immune cells. | Theranostics | 2025 | https://conductscience.org/library/papers/40303343 | PubMed |
| 40075112 | Activin A affects colorectal cancer progression and immunomodulation in a stage dependent manner. | Sci Rep | 2025 | https://conductscience.org/library/papers/40075112 | PubMed |
| 40064965 | Kallikrein-8 mediates furin-independent Activin-A precursor processing to stimulate tumor growth in melanoma. | Nat Commun | 2025 | https://conductscience.org/library/papers/40064965 | PubMed |
| 39837814 | Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/39837814 | PubMed |
| 39727149 | Activin A promoted the anti-tumor effect of ActRIIA high CD8+ T cells in mouse hepatoma. | Cancer Med | 2025 | https://conductscience.org/library/papers/39727149 | PubMed |
| 39448726 | Stepwise release of Activin-A from its inhibitory prodomain is modulated by cysteines and requires furin coexpression to promote melanoma growth. | Commun Biol | 2024 | https://conductscience.org/library/papers/39448726 | PubMed |
| 39253924 | Activin A-Targeted Therapy in Cancer: An Updated Review on Challenges and Opportunities in Clinical Translation. | Curr Pharm Des | 2026 | https://conductscience.org/library/papers/39253924 | PubMed |
| 39223366 | INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/39223366 | PubMed |
| 39223291 | Activin A plays an essential role in migration and proliferation of hepatic stellate cells via Smad3 and calcium signaling. | Sci Rep | 2024 | https://conductscience.org/library/papers/39223291 | PubMed |
| 38893071 | Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893071 | PubMed |
| 38727264 | Activin A, a Novel Chemokine, Induces Mouse NK Cell Migration via AKT and Calcium Signaling. | Cells | 2024 | https://conductscience.org/library/papers/38727264 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35580932
GET https://conductscience.org/api/papers/v1/35580932/references?page=2